Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Retatrutide is an investigational triple receptor agonist (GLP-1, GIP, and glucagon) currently in clinical trials for obesity and type 2 diabetes
Improved sleep quality and mental focus often occur within the first 1 to 4 weeks
Further studies are warranted to better characterize this potential adverse effect and guide agent selection in patients at risk for SIBO
1,16 References Gul, M., Liu, Z., Haq, I., et al
These contain high levels of fructose or sorbitol that ferment readily in a slow-moving gut
US$ 22.62
US$ 21.22
US$ 24.16
US$ 21.84
US$ 25.65
US$ 25.59
US$ 26.78
